PMID- 25721605 OWN - NLM STAT- MEDLINE DCOM- 20151204 LR - 20150321 IS - 1573-7217 (Electronic) IS - 0167-6806 (Linking) VI - 150 IP - 2 DP - 2015 Apr TI - Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1. PG - 255-63 LID - 10.1007/s10549-015-3318-2 [doi] AB - The objective of this study is to investigate interactions between adipocytes and breast cancer cells, and identify the responsible factors for the observed effects. In 27 breast cancer patients undergoing mastectomy, mammary adipose tissue was obtained from the breast quadrant bearing the tumor and corresponding non-tumoral quadrant. Isolated normal breast adipocytes (NBAs) and cancer-associated adipocytes (CAAs) were cultured in collagen gels to mimic the in vivo environment. Immunohistochemistry, qRT-PCR, and cell proliferation assays were performed to analyze adipocyte phenotypes. MCF7 and MDA-MB-231 breast cancer cell lines were co-cultured with adipocytes to detect phenotypic changes. Migration of MCF7 and MDA-MB-231 cells was assessed in NBA- and CAA-conditioned media. Cytokine levels in conditioned media were measured by cytokine array. Migration assays were repeated using conditioned media containing neutralizing antibodies. NBAs and CAAs lost their morphological phenotype in culture, acquiring a spindle-like shape, and CAAs showed higher cell proliferation, suggesting reversion to an immature phenotype. In co-cultures with MCF7 or MDA-MB-231 cells, NBAs exhibited increased cell proliferation, indicating acquisition of the immature phenotype of CAAs. MCF7 and MDA-MB-231 showed higher migration in a CAA-conditioned medium than in an NBA-conditioned medium. Cytokine array analysis of conditioned media revealed higher levels of interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) in the CAA-conditioned medium. Neutralization experiments using antibodies against IL-6 or MCP-1 showed abrogation of migration-enhancing effects of the CAA-conditioned medium. Adipocytes revert to an immature and proliferative phenotype in the presence of breast cancer cells, and promote cancer cell migration via adipokines including IL-6 and MCP-1. FAU - Fujisaki, Kaoru AU - Fujisaki K AD - Department of General Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-Ku, Chiba, 260-0856, Japan. FAU - Fujimoto, Hiroshi AU - Fujimoto H FAU - Sangai, Takafumi AU - Sangai T FAU - Nagashima, Takeshi AU - Nagashima T FAU - Sakakibara, Masahiro AU - Sakakibara M FAU - Shiina, Nobumitsu AU - Shiina N FAU - Kuroda, Masayuki AU - Kuroda M FAU - Aoyagi, Yasuyuki AU - Aoyagi Y FAU - Miyazaki, Masaru AU - Miyazaki M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150227 PL - Netherlands TA - Breast Cancer Res Treat JT - Breast cancer research and treatment JID - 8111104 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (IL6 protein, human) RN - 0 (Interleukin-6) SB - IM MH - Adipocytes/physiology MH - Breast Neoplasms/*pathology MH - *Cell Movement MH - Cell Proliferation MH - Cell Shape MH - Chemokine CCL2/*physiology MH - Coculture Techniques MH - Epithelial-Mesenchymal Transition MH - Female MH - Humans MH - Interleukin-6/*physiology MH - MCF-7 Cells EDAT- 2015/02/28 06:00 MHDA- 2015/12/15 06:00 CRDT- 2015/02/28 06:00 PHST- 2014/12/15 00:00 [received] PHST- 2015/02/19 00:00 [accepted] PHST- 2015/02/28 06:00 [entrez] PHST- 2015/02/28 06:00 [pubmed] PHST- 2015/12/15 06:00 [medline] AID - 10.1007/s10549-015-3318-2 [doi] PST - ppublish SO - Breast Cancer Res Treat. 2015 Apr;150(2):255-63. doi: 10.1007/s10549-015-3318-2. Epub 2015 Feb 27.